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Abstract
Filtration can achieve circulating tumor cell (CTC) enrichment from blood. Key parameters such as flow-rate, applied
pressure, and fixation, vary largely between assays and their influence is not well understood. Here, we used a filtration
system, to monitor these parameters and determine their relationships. Whole blood, or its components, with and without
spiked tumor cells were filtered through track-etched filters. We characterize cells passing through filter pores by their
apparent viscosity; the viscosity of a fluid that would pass with the same flow. We measured a ratio of 5?104:102:1 for the
apparent viscosities of 15 mm diameter MDA-231 cells, 10 mm white cells and 90 fl red cells passing through a 5 mm pore.
Fixation increases the pressure needed to pass cells through 8 mm pores 25-fold and halves the recovery of spiked tumor
cells. Filtration should be performed on unfixed samples at a pressure of,10 mbar for a 1 cm2 track-etched filter with 5 mm
pores. At this pressure MDA-231 cells move through the filter in 1 hour. If fixation is needed for sample preservation, a
gentle fixative should be selected. The difference in apparent viscosity between CTC and blood cells is key in optimizing
recovery of CTC.
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Introduction
Circulating tumor cells (CTC) are cancer cells disseminated into
the blood from primary or metastatic sites. Clinical trials have
shown that the presence of CTC is predictive of survival in several
types of cancer, including breast, prostate, colon, gastric, small and
non-small cell lung carcinoma and melanoma [1–7]. Because the
typical CTC concentration is 1 CTC in 1 mL of blood [8]
(compare to 5?106 white cells and 5?109 red cells), enrichment of
CTC is the first step in most CTC enumeration approaches.
Selective CTC enrichment is achieved either by positive selection,
targeting antigens on the cell surface of the CTC not expressed by
blood cells, or by selective depletion of the blood cells targeting
antigens not expressed on CTC [9–15]. The downside of using
antibody mediated positive enrichment is that cells with low or no
expression of the antigen are lost. Antigen expression independent
techniques could select CTC based on the physical differences
between tumor and blood cells, for example: stiffness [16], density
[17], size by a filter membrane [18–28] or other filter type [29,30].
Recent filtration methods [20–28] report much improved recov-
eries compared to early methods [18,19]. However, large
unexplained differences in sample fixation, sample dilutions, flow
rates and pressures across the filters exist between approaches as
summarized in table 1. We expect that these parameters affect
whether a large cell passes through a small pore as they influence
red and white blood cells [31–33], and therefore it is not feasible
that all parameter combinations in table 1 are optimal. Here we
investigate which of these parameters are indeed important for
enrichment of CTC using filtration techniques. After identification
of the important parameters for CTC enrichment the filter
characteristics that are optimal for CTC enrichment were
investigated in an accompanying paper[34].
Materials and Methods
Blood samples
Healthy volunteers aged 20–55 gave written informed consent
before donating blood, the study protocol was approved by the
METC ethics board (Enschede, The Netherlands). Blood from
EDTA vacutainers (BD, Franklin Lakes, NJ, USA) was processed
within 12 hours after draw. Unless otherwise noted, each data
point represents the average of three repeat measurements. For
each repeat we used blood from a different donor, but a whole
experiment was done with the same three donors.
Cell culture and cell staining
Spiking experiments were performed with cells from the
prostate carcinoma cell line PC3-9, a sub-clone of the PC3 cell
line [35] kindly provided by Immunicon (Huntingdon valley, PA,
USA) and the breast carcinoma cell lines SKBR3 and MDA-231
obtained from ATCC (Manassa, VA, USA). PC3-9 cells were
cultured using RPMI (Sigma, St. Louis, MO, USA) while the
SKBR3 and MDA-231 cells were cultured in Dulbecco’s Modified
Eagle Medium (Sigma). Culture media were supplemented with
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10% fetal bovine serum (Gibco, Invitrogen, Carlsbad, CA, USA),
1% penicillin-streptomycin (Gibco) and 1% L-Glutamin (Sigma).
PC3-9 were stained with CellTracker Green Bodipy, MDA-231
with CellTracker Orange CMTMR (both Invitrogen) and SKBR-
3 with both stains. Cells were incubated in culture media for
24 hours at 37uC with 50 mM CellTracker Green and/or 5 mM
CellTracker Orange prior to harvesting with 0.05% trypsin
(Gibco). While still in the filter holder, the filter was washed with
ethanol to fix the cells to the filter, in a series of increasing
concentration from 70 to 100%. The filter was dried in vacuum
followed by staining of nuclei with 8mM Hoechst 33342
(Invitrogen).
Filtration setup
A filtration setup was constructed to allow simultaneous
measurement of pressure and control of flow rate, figure 1. The
flow through the filter consists of two parts, the sample flow and a
PBS (phosphate buffered saline) flow. If desired, the PBS flow can
be used to dilute the sample. Dilution of 1:x means that 1 part
sample is diluted in x-1 parts of PBS. For the sample flow, a sample
is loaded into a 1 mL or 50 mL syringe (Plastipak, BD, Franklin
Lakes, NJ, USA) with a 21 gauge needle (Microlance 3, BD) and
placed onto a NE-1000 syringe pump (New Era Pump Systems,
Farmingdale, NY, USA). The PBS flow originates from a stainless
steel tank (Alloy products, Waukesha, WI, USA) pressurized with 2
bar N2. To reduce uptake of N2 into the PBS, the PBS is contained
inside a plastic bladder inside a water filled tank. PBS is filtered by
an inline 0.2 mm filter (mini Kleenpak, Pall, Mijdrecht, The
Netherlands) and the flow rate is controlled by a flow sensor
(CoriFlow, Bronkhorst, Veenendaal, Netherlands). The pressure
difference across the filter is measured by a 0–300 mbar pressure
sensor (PR-41X, Keller, Winterthur, Switzerland). During filtra-
tion, the pressure increases until a stable situation is reached or
pressure exceeds 300 mbar. The stable pressure was recorded.
Filters
Track-etched filters with pore sizes of 5 mm and 8 mm pore size,
a diameter of 13 mm and a thickness of 6–11 mm were used
(Nucleopore, Whatman, GE, Maidstone, UK). The number of
pores on a track-etched filter were counted with a bright field
image of 1 mm2 of filter area using a fluorescent microscope with
46NA=0.13 objective (E-400, Nikon, Melville, NY, USA). The
5 mm pore size filters contained 3.5?105 pores and the 8 mm
contained 9.2?104 pores in a filter surface of 102 mm2. Inspection
of the filters by bright field microscopy indicates that (1) the pores
are distributed randomly, that (2) 3–10% of the pores are so closely
spaced that one 15 mm diameter cell may block several pores, and
that (3) 1–2% of pores consist of merged holes. The pores
constitute approximately 5–7% of the filter area. Since filter
properties vary between different lots, only one lot of each pore
size was used. The filters were mounted in plastic filter holders
(Swinney, Pall). Before use, a filter was placed in a holder, primed
with PBS and placed in ,50 mbar vacuum for 30 minutes, which
displaced trapped air form the filter pores, but did not evaporate
more than 10% of the PBS.
Relation between number of pores, pressure, and flow
rate
The relation between pressure and flow rate for a filter was
determined by increasing the flow rate from 0–800 mL/h in steps
of 50 mL/h and recording flow rate and pressure. To determine
the impact of the number of pores, we covered parts of the 5 and
8 mm track-etched filters with different aperture plates leaving 2, 4,
8, 16, 32 or 57 mm2 of the filter area open. Viscosity of PBS was
assumed to be equal to water [36], 0.9 mPa?s.
Impact of sample dilution on pressure
To determine the impact of sample dilution on the pressure
difference, we filtered 1 mL of whole blood through a 5 mm track-
etched filter with dilutions of 1:1, 1:4 and 1:16 and total flow rates
of 50, 200 and 800 mL/h. Dilutions were set at 1:4, and sample
flow rate to 25 mL/h for all other experiments.
Filtration of blood fractions, culture cells and beads
Major components of whole blood include white blood cells
(WBC), red blood cells (RBC) and serum. Blood was split into
Table 1. Filtration methods and conditions.
Reference Pressure (mbar) Pore size (mm) Fixation Sample dilution
Zheng 2011 [26] 35 7* none 1:10
Zheng 2007 [23] 35 10 PFA` 1:10
Tan 2010 [30] 50 5* none none
Vona 2000 [28] 300 8 PFA` 1:101
Desitter 2011 [22] 700{ 6.5 none 1:81
700{ 7.5 PFA` 1:71
Kahn 2004 [21] N/A 8 50% EtOH 5:41
*estimated pore size from 3D filter structure, {pressure at start of filtration,
`paraformaldehyde, 1red blood cells lysed/removed.
doi:10.1371/journal.pone.0061774.t001
Figure 1. Setup for filtration. The setup allows for control of either
pressure, flow rate or sample dilution factor while monitoring the other
two parameters.
doi:10.1371/journal.pone.0061774.g001
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fractions by means of centrifugation. A 10 mL tube of blood was
centrifuged at 3006g for 10 minutes. We collected the top 1 mL of
serum, the bottom 1 mL of red blood cells as well as the buffy coat
layer together with 0.5 mL of serum above and 0.5 mL of red
blood cells below this layer. Each fraction was reconstituted to
their original concentration with PBS-1%BSA (bovine serum
albumin). At a hematocrit of 60%, the 1 mL of serum was diluted
with 1.5 mL of PBS-1%BSA and the 1 mL of RBC was diluted
with 0.67 mL PBS-1%BSA. The buffy coat was diluted with 9 mL
of PBS-1%BSA. We did not lyse the red blood cells in the buffy
coat sample to prevent swelling of the WBC. As a result the sample
contains RBC, but at a concentration ,12 times lower than the
RBC sample.
For culture cells, we attempted to pass 106 MDA-231, PC3-9
and SKBR-3 culture cells through a 5 mm pore track-etched filter
with 0.35?106 pores, or three times more cells than pores. To verify
the size-selectivity of the setup, we filtered a solution with 106
10 mm, 6 mm and 4 mm polystyrene beads (size calibration beads,
Invitrogen) through a 5 mm filter. The filtrate was enumerated on
a FACSARIA II flowcytometer (BD) using forward and side
scatter signals and the beads on the filter enumerated using bright
field imaging on a microscope with 46NA=0.13 objective.
Whole blood cell filtration
The force pushing cells through a filter is the pressure DP across
the filter times the cross section Apore of the pore. The interaction
of a cell with a pore can be modeled by describing the cell as a
droplet characterized by an apparent viscosity [37], which is
dependent on the cell surface tension, cell and nucleus viscosity
[38], the sample temperature [39], and the deformation required
to pass through a pore [40]. Below a critical pressure the surface
tension of the cell membrane will counter the force pushing the
cell into the filter pore. At pressures in excess of this critical
pressure, the cell will move into the pore at a rate determined by
the apparent viscosity. Since the apparent viscosity is cell
dependent, a condition may exist where the critical pressure is
exceeded for blood cells, but not for CTC. In this case filtering at a
pressure below the CTC critical pressure will be an effective
enrichment method. On the other hand, if the critical pressure for
CTC is similar to blood cells, filtration must take place at a
pressure in excess of the critical pressure for CTC to prevent
clogging of the filter. At pressures in excess of the critical pressure
for CTC, all cells in the sample will pass through a filter, each with
a speed determined by their apparent viscosities.
For a filter with N pores of diameter d, height h and sufficiently
low porosity (,10%), steady state laminar flow pressure difference
across the filter when an incompressible fluid with viscosity m
passes through at flow rate Q is given by [41–43]:
DP~m
128h
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z
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Q
N
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Q
N
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R is the pore resistance, derived for a pore with sharp edges. For
Whatman nucelopore filters h is approximately 10 mm, d is
approximately 5 or 8 mm. When h..d equation 1 reduces to the
equation for Poiseuille flow. For all our experimental conditions
the Reynolds number is smaller than 100 unless a filter is nearly
clogged. It is therefore sufficient to consider laminar flow
conditions.
Estimation of cell speed and apparent viscosity
Describing the cells as droplets suspended in a diluent, with the
assumption that no cells are permanently retained by the filter and
no fibrin aggregates that may clog the filter are present, the
pressure difference must be equal for each of the components.
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With subscripts used to indicate the contribution of the diluent
(dil), cells (cell) or diluent and cells combined (total). Further
Qcells =QtotalCcellVcell, where Ccell is the (number) concentration of
cells in the sample and Vcell is the cell volume. We can now use this
equation to determine the number of pores that are needed to pass
the sample diluent Ndil. The rest of the pores Ncell =Ntotal2Ndil are
occupied by cells passing through. The unknown apparent
viscosity mappcell for each cell type can now be determined by
filtering a single cell type with known concentration and cell
volume. We assume an average of 90 fl for the red blood cell
volume [44]. Other cells are assumed to be spherical with a radius
of 10 mm for WBC and 15 mm for MDA-231. The cell speed v
inside the pore is then derived according to equation 3, with Apore
the cross section of a pore.
v~
Qcell
NcellApore
ð3Þ
The data from the filtration of blood fractions and culture cells
was used to determine apparent viscosity and cell speed for each
cell type. For the WBC/RBC cell mixture in the components
experiment, the speed of the WBC was estimated by subtracting
the number of pores clogged by RBC as derived from the same
experiment.
Spiked samples and cell recovery for different fixations
Thirty mL of blood was collected and spiked with 300 pre-
stained MDA-231, SKBR3 and PC3-9 per mL of whole blood.
The total of 900 cells is expected to occupy less than 1% of the
total number of pores, yet is sufficiently high for cell counting.
Concentration of cells in the spiking stock was determined by
counting at least 200 cells of each type on a counting chamber
(Neubauer, Lauda-Ko¨nigshofen, Germany). The spiked blood was
split into three fractions of 10 mL. The first fraction was processed
unfixed. To the second fraction the content of a 10 mL CellSave
preservative vacutainer tube (Veridex, Raritan, NJ, USA) was
added and incubated for 3–5 hours. The third fraction was split
into 1 mL aliquots and 1060.5 minutes prior to commencement
of the filtration procedure 1 mL of a 0.8% formaldehyde solution
(PFA) was added to each aliquot. For filtering, the total flow rate
was set at 100 mL/h, with a 1:4 dilution.
After filtration the filter was fixed with an ethanol series
increasing up to 100% to fix the cells to the filter. The samples
were enumerated by imaging the filter on a fluorescence
microscope as described above. False color images (CellTracker
Orange: red, CellTracker Green: green, Hoechst 33342: blue)
were generated in which the PC3-9 appear light green, the MDA-
231 pink and the SKBR-3 yellow, figure 2. Cells with only a
nucleus are assumed to be white blood cells (blue).
Filtration Parameters Influencing CTC Recovery
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Results and Discussion
Relation between flow rate, pressure and number of
pores is predicted by the model
A custom filtration setup was used to investigate the influence of
pressure, sample dilution and fixation on the enrichment of large
cells from whole blood by means of filtration. A linear relation
between the number of pores, total flow rate and pressure across
the filter was expected for laminar flow conditions, equation 1, and
confirmed experimentally using phosphate buffered saline (PBS),
as can be seen for different numbers of 5 mm pores in Figure 3.
The resistance R is 1.2460.02 mm23, or 48% higher than
predicted by equation 1. For the 8 mm filter, we obtain
R=0.2660.18 mm23, with a predicted R of 0.15 mm23. The
deviation between the theoretical R and the determined R is
relatively small and could be caused by differences between real
and nominal thickness of the filter or pore size, or differences in
modeled versus real pore shape. The variation in R is attributable
to experimental repeatability. We applied equation 1 to determine
the number of pores that pass PBS and derive from this the
number of pores that pass cells according to equation 2.
In a blood sample the sample flow rate dominates
pressure
Figure 4, panel A shows the relation between total flow rate,
sample dilution and pressure, averaged across 3 donors. At the
same total flow rate, pressures are 10 times higher for undiluted
blood than for 1:16 diluted samples. However, relations between
pressure and sample flow rate are linear for each donor (R2 for
each donor at each dilution.0.94). Figure 4, panel B shows that
the pressure is primarily determined by the sample flow rate, not
the total flow rate. This demonstrates that the key parameter is the
arrival rate of cells on the filter. The slope between three donors
varied by 640%, possibly because their hematocrit or white cell
concentration differed [31–33].
Three total flow rates (50 mL/h, 200 mL/h, and 800 mL/h)
were measured at a sample flow rate of 50 mL/h. In these
conditions, the pressure varied from 10.5–17.2 mbar, implying
that on average 15?103 to 144?103 pores (4–41% of the total) were
Figure 2. Counting cells on a track-etched filter. False color image of pre-stained culture cells and WBC on a track-etched filter using 46(A) and
106 (B) magnification.
doi:10.1371/journal.pone.0061774.g002
Figure 3. Pressure versus inverse of open pores, for different
flow rates. The number of pores on a 5 mm track-etched filter was
decreased by reducing the number of available filter pores with
aperture plates. The fits through the data were used to estimate an
average relationship between pressure (P; mbar), flowrate (Q; mL/h) and
number of pores (Nopen) by fitting the resistance to flow (R); P = mR Q/
Nopen. With the viscosity m at 0.9?1023 Pa?s, R is 1.2860.02 mm23.
doi:10.1371/journal.pone.0061774.g003
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needed to pass the diluent (plasma and PBS), while the rest of the
pores (207?103–336?103) were filled with a cell passing at much
lower speed. For a concentration of 5?109 predominantly red
blood cells per mL of sample the average speed of a cell passing
through a pore is 0.9–1.5 mm/s while the average fluid flow speed
is 48–78 mm/s inside the pores. The arrival rate of cells on the
filter dominates pressure but a higher dilution results in a small
increase of pressure, thus slightly reducing recovery. Nevertheless,
we decided to set dilution at 1:4 to clear the remaining blood from
the filter holder in a timely fashion.
RBC and WBC contribute most to the pressure
To confirm that the cells are indeed the dominant factor we
determined the relation between pressure and flow rate for blood
components. Panel A of figure 5 shows a 1:4 dilution with 3
different total flow rates (100, 200 and 400 mL/h). The different
components tested include RBC (5?109/mL), a mixture of RBC
(4?108/mL) and WBC (5?106 WBC/mL), serum, and PBS-1%BSA
solution. The serum leads to a slight increase in pressure compared
with PBS-1%BSA. WBC and RBC contribute almost equally to
the pressure difference, even though RBC are 1000 times more
frequent.
A 15 mm cell can easily pass through a 5 mm pore while a
6 mm bead does not pass
We filtered 106 PC3-9, SKBR-3 and MDA-231 culture cells at
different flow rates using 5 mm track-etched filters. We expected
the filter to clog (pressure to rise above 300 mbar) before 0.35?106
culture cells were passed through a track-etched filter with
0.35?106 pores, as these cells are more than three times larger
than the pore size. Both PC3-9 and SKBR-3 clogged at all flow
speeds when 0.3?106 up to 0.5?106 cells had been injected. The
MDA-231 cells only clogged the filter at the highest total flow
speed of 400 mL/h, but 106 cells passed the filter at total flow
speeds of 50, 100 and 200 mL/h. Figure 6 shows the pressures and
flow rates for the three cell lines, with each data point representing
the average of triplicate measurements and error bars indicating
the standard deviation. The implication of MDA-231 not clogging
the filter was that a substantial fraction of these cells passed the
5 mm pores. Considering only the ratio of spiked cells to pores, at
least 65% of MDA-231 cells passed the filter. The loss is likely to
be higher because a single MDA-231 cell could block multiple
pores. In addition, the PC3-9 and SKBR-3 runs with the lowest
flow speed clogged when more than 40% of the sample had been
injected, suggesting that also for these cell lines a substantial
fraction of cells had passed the filter.
To verify the size selectivity of the 5 mm filter, the filtrate of a
solution containing 106 polystyrene beads with diameters of 4, 6,
and 10 mm was investigated. We found that 26% of the 4 mm
beads injected, 0.35% of the 6 and 0.0% of the 10 mm beads had
passed the filter. The beads not found in the filtrate were found on
the filter. It was possible to pass 15 mm MDA-231 cells through a
pore of only 5 mm at relatively low pressures of 80 mbar, while
6 mm polystyrene beads were retained. This difference in behavior
between beads and cells may be explained by a difference in
stiffness. Therefore, the passage of a cell through a pore was
modeled as a high viscosity stream passing through a filter.
MDA-231 cells pass at least 4300 times slower through a
5 mm pore than a WBC
The experimental setup and equation 3 were used to estimate
the speed with which an MDA-231, WBC or RBC passes through
a pore and derived from this the apparent viscosity of a cell relative
to the pore, figure 7. Due to the large relative error in the pressures
Figure 4. Sample flow rate determines pressure drop across filter. Whole blood was filtered through a 5 mm track-etched filter at total flow
rates of 50, 200 and 800 mL/h without sample dilution and with 4 or 166sample dilution. (A) Total flow rate versus pressure. In contrast with figure 3,
the total flow rate is not the main factor contributing to the pressure across the filter when cells are present in the sample. (B) Sample flow rate versus
pressure. When the pressure difference is plotted as a function of the sample flow rate, there appears to be a linear relation.
doi:10.1371/journal.pone.0061774.g004
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detected for the 8 mm filters we did not estimate the speed of
passage for this pore size. From linear fits through the data, we
find that at the same pressure, the passage of RBC is
approximately 120-fold faster than the passage of WBC and
MDA-231 cells are 430 times slower than the WBC. The high
viscosity stream approximation was used to determine the
apparent viscosity of each cell type from the slope between
pressure and time of passage. The apparent viscosity for 5 mm
pores is estimated at 0.03560.010 Pa?s for RBC
(DP= 5216 mbar), 3.262.5 Pa?s for WBC (DP=5213 mbar),
and of 1.6?10360.2?103 Pa?s for MDA-231 cells
(DP= 852300 mbar). The SKBR-3 and PC3-9 cells clogged the
filter even at the lowest speed, their apparent viscosity must be
larger than 2?103 Pa?s. Experiments with granulocytes suggest
cells are shear thinning [39,45], with apparent viscosity reducing
from 2.4?103–4.4?103 Pa?s [46] at 0.2 mbar to 30–200 Pa?s at
pressures near 5 mbar [39,47–49]. If this holds true for cells
derived from tumor cell lines, the time needed to pass a pore is
even larger at lower pressures. The estimates for WBC and RBC
apparent viscosity as determined here in bulk cell suspensions are
similar to those determined using micropipette aspiration at
similar pressures and pore sizes. We found 3.2 Pa?s for WBC,
compared to 30–200 Pa?s for granulocytes reported in the
literature [39,47–49]. For RBC the apparent viscosity was
determined to be 35?1023 Pa?s and for MDA-231 cells we
determined an apparent viscosity of 1.6?103 Pa?s at a pressure of
100 mbar and greater than 2?103 Pa?s for SKBR-3 and PC3-9
culture cells. At a pressure of 10 mbar, the speed of a RBC in a
5 mm pore is 1.5 mm/s, compared to 12?1023 mm/s for a WBC.
Literature values are comparable with WBC entry speed into a
glass capillary of 36?1023 mm/s [50] and a 700–1000 fold
difference between passage time through a filter of RBC and WBC
[51,52]. At a pressure of 100 mbar an MDA-231 cell passes in
360 s. Assuming that the apparent viscosity is independent of
Figure 5. All blood components contribute to total pressure. Major blood components RBC, WBC and serum were filtered across 5 (panel A)
and 8 (panel B) mm track-etched filters until pressure reached a plateau (y-axis). Whiskers show the standard deviation from three measurements.
Data-points were all measured at flow rates of 100, 200 and 400 mL/hr, but were slightly offset to facilitate reading of the graph. Inspection of the
filters after filtering using bright field imaging and fluorescence imaging of the Hoechst 33342 stain showed no evidence of capture of RBC, while
103–104 WBC were found on each filter.
doi:10.1371/journal.pone.0061774.g005
Figure 6. Culture cells can pass through small pores at low
pressures. The y-axis shows pressure drops when 1.0?106 SKBR3, PC3-9
or MDA-231 cell lines are filtered across 5 mm track-etched filters with
0.35?106 pores. Data points were all measured at total flow rates of 50,
100, 200 and 400 mL/hr, but were slightly offset to facilitate reading of
the graph. The median cell diameter of PC3-9 = 19.0 mm, SKBR-3 cells
16.4 mm and MDA-231= 15.4 mm and were thus expected to occupy all
pores. All samples with SKBR-3 and PC3-9 samples clogged the filter
and the sample with MDA-231 clogged at a flow rate of 400 mL/h.
doi:10.1371/journal.pone.0061774.g006
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pressure, at 10 mbar an MDA-231 cell would pass the filter in one
hour.
An important difference between the apparent viscosities as
determined by micropipette aspiration and those determined using
a filter is that the entire cell can be aspirated into a capillary, while
WBC and MDA-231 cells are larger than the pore; the pore
volume is 35% of the WBC volume and 11% of the MDA-231 cell
volume. As a result, the cells need to deform less to pass through a
pore than to enter a long capillary, and thus have lower apparent
viscosity. The relative difference between apparent viscosity of
blood cells and tumor cells is important because it determines
whether captured tumor cells will be on the filter at the end of
filtration. It is unknown if these tumor cell lines are a good model
for CTC, as very little is known about the physical properties of
CTC. Many approaches to determine such properties, including
the approach we applied, require large numbers of cells, while
CTC in patients are extremely rare. Despite differences between
our bulk method and micropipette experiments with similar pore
size, the latter could be applied to determine the apparent viscosity
of real CTC, an advantage since these require only 1 cell per
determination. In addition, micropipette experiments could be
used to determine the influence of various parameters such as
pressure and sample temperature [39] on the apparent viscosities
of blood cells and various cultured tumor cells.
Micropipette aspiration experiments have shown that a critical
pressure exists for which a cell is not pulled into the pipette, due to
surface tension of the cortex. For granulocytes this critical pressure
is 0.1 mbar on a 5 mm pore [53], while for various cancer cell lines
this pressure is 2–8 mbar [54]. The apparent viscosity is much
higher when determined at a pressure slightly above the critical
pressure. This suggests that, for a 5 mm pore size, the sample
should be filtered at a pressure near 2 mbar in order to retain all
captured culture cells. However filtration of 1 mL of blood at this
pressure takes approximately 15 minutes on a 1 cm2 track etched
filter with 5 mm pores, resulting in flow that is extremely slow. This
leads to uneven sample distribution across the filter due to gravity,
defeating the purpose. While it is not practical to filter at a
pressure below the critical pressure, apparent viscosity is highest
near the critical pressure, which suggests that filtration at pressures
near the critical pressure of a CTC will yield better results than
filtration at much higher pressures.
Fixation dramatically increases the pressure needed to
push cells through a pore
Fixation can be used to change the apparent viscosity, to
investigate its influence the recovery of cultured tumor cells as a
function of fixation was determined by spiking 300 cells of 3
different cell lines into 1 mL of blood. The recovery for each cell
line, fixation type and pore size is shown in figure 8. Pressure
across the filter and sample purity is shown below the x-axis. The
purity was defined as the percentage of cancer cells of all cells
recovered. Unfixed samples had highest recovery and purity at the
lowest pressure. CellSave fixed samples had recovery slightly lower
than unfixed samples, with 3–8 fold higher pressures, and lower
purity. PFA fixed samples clogged the 5 mm filter. PFA fixed
samples on the 8 mm filter had lower recovery and lower purity
than the other samples, while the pressure was 25 fold higher
compared to unfixed samples. Overall, the 5 mm and 8 mm track-
etched filters with unfixed samples performed similar in terms of
recovery but sample purity was an order of magnitude higher on
the 8 mm track-etched filter. Fixation increases the apparent
viscosity of a cell, which increases the pressure needed to pass a cell
through the same pore size in the same time, or increases the pore
size needed at constant pressure and time. The lower sample
purity of PFA fixed samples compared to unfixed samples suggests
that the difference in passage time and apparent viscosity between
culture cells and white cells is reduced after fixation.
All other experiments presented here were performed with fresh
unfixed blood. It is conceivable that processing of older samples
requires some form of fixation for sample preservation, for
example to allow processing in a remote laboratory. CellSave
[55] is a gentle fixative used to preserve CTC in blood prior to
immunomagnetic enrichment, and may prove to be a good
preservative for enrichment of CTC prior to size based filtration.
Filtration process
From the results reported in the literature and in this
manuscript we interpret the filtration process as follows: cells
and diluent arrive on the filter. Cells are pulled to a pore by fluid
passing through that pore and proceed to slowly pass through,
with cells with a higher apparent viscosity passing through slower,
resulting in a relative enrichment of cells with higher apparent
viscosity. A pore is occupied by a cell most of the time and passes
diluent in short bursts between cells. If the pressure during
filtration is lower than the critical pressure for only one cell type in
the suspension, this cell type has an infinite apparent viscosity and
will be retained. This is difficult to achieve in any practical setup,
and pressure during filtration is most likely higher than the critical
pressure for all cell types. Thus all cells types will eventually pass
through the filter, resulting in reduced recovery of tumor cells from
larger sample volumes (i.e. longer filtration). If possible the
filtration time should be shorter than the time a tumor cell needs
to pass the filter at the operating pressure so recovery is
maximized. If this is not possible it could be mitigated by stacking
multiple filters on top of each other, thus dramatically increasing
the relative difference in passage time between tumor cells and
blood cells. If cortical tension returns the cells to the top of the
filter when no pressure difference exists, the same could be
achieved by intermittent flow, passing blood cells in bursts and
then waiting for the tumor cells to return to the top of the filter
between bursts.
Figure 7. Estimated speeds for different cells. Estimated speed
inside a filter pore versus pressure across the filter for white (WBC) and
red blood cells (RBC) and MDA-231 culture cells. Dashed lines are fits of
v!DP. All three MDA-231 samples at a flow rate of 400 mL/h clogged.
doi:10.1371/journal.pone.0061774.g007
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Conclusions
While CTC enrichment by filtration has been first performed
more than 50 years ago [18,19], a systematic comparison of assay
parameters was lacking to date. We conclude that the optimal
conditions include a pressure close to or lower than 10 mbar for a
pore size of 5 mm and no fixation.
Total processing time is limited because CTC still move slowly
through the filter with a speed depending on the operating
pressure; at a pressure of 10 mbar filtration should be completed
in less than 1 hour for capture of MDA-231 cells. Sample dilution
is not strictly needed, and has a small negative influence on
recovery. If fixation is needed for sample preservation, a gentle
fixative should be used, in which case the ideal filtration pressure
will probably be higher.
To further optimize the conditions, the difference between the
apparent viscosities of CTC and other blood component has to be
maximized. Tumor cell lines are of limited use since their
properties may not sufficiently resemble CTC. Since CTC are
very rare, a purely empirical approach that requires large numbers
of CTC has to be supplemented by other methods to determine
the mechanical properties (surface tension, elasticity) of different
types of CTC under various conditions (fixation, buffers, etc.) and
predict the apparent viscosities as a function of pore size and
pressure from these properties.
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